Nicotinamide Riboside (NR) Chlorideとは？用途・使用量・代替品・規格

Nicotinamide Riboside (NR), chemically named 3-(Aminocarbonyl)-1β-D-ribofuranosylpyridinium, is a nucleoside derivative of vitamin B3 and an important precursor in the biosynthesis of Nicotinamide Adenine Dinucleotide (NAD+). Its chemical formula is C11H16N2O5, molecular weight is 256.26, CAS number is 1341–23–7, and EINECS number is 606–017–4. In chemical structure, NR is composed of a nicotinamide group and a ribose group connected via a glycosidic bond, with no phosphate group. This structural feature endows NR with higher cell membrane permeability compared to NMN. As one of the core members of the NAD+ precursor molecular family, NR can be converted to NMN via NRK (nicotinamide riboside kinase) catalysis, and then further to NAD+, thereby participating in key biological processes including cellular energy metabolism, DNA repair, mitochondrial function regulation, and activation of the sirtuin longevity proteins. NR is naturally present in trace amounts in cow's milk and human milk, and dietary intake alone cannot provide sufficient supplementation, making oral supplements the mainstream intake route. NR appears as a white to off-white crystalline powder, odorless, slightly bitter, and moderately hygroscopic. Its aqueous solution is weakly acidic. At room temperature, it should be stored away from light, sealed, and protected from moisture. As the first NAD+ precursor dietary supplement ingredient to receive FDA New Dietary Ingredient (NDI) recognition and achieve commercial success, NR occupies a solid core position in the global anti-aging and healthy aging market, with Niagen® as its flagship brand, representing one of the most commercially mature and clinically well-studied NAD+ precursor ingredients.

NR is recognized as one of the most commercially mature and clinically well-studied ingredients in the NAD+ precursor field, occupying a rapidly rising core position in global dietary supplements and the anti-aging market. Its most prominent core advantages include: a clear and robust clinical evidence chain, high-efficiency cellular uptake mechanisms, extensive basic scientific research backing, multiple health benefits, and increasingly refined green bio-manufacturing processes. 1 North American Market Leader: The First Commercially Available NAD+ Precursor Dietary Supplement NR is the first NAD+ precursor ingredient in human history to receive FDA New Dietary Ingredient (NDI) recognition and be commercialized as a dietary supplement, launched globally by ChromaDex under the flagship brand Niagen®. Leveraging ChromaDex's robust intellectual property portfolio of over 90 patents, NR has established an unshakeable commercial competitive barrier in the global NAD+ precursor supplement market, becoming a core category in the North American NAD+ precursor dietary supplement market with globally leading brand awareness and consumer trust. 2 Most Abundant Clinical Evidence: Numerous Published Human Clinical Trials NR currently possesses the most abundant human clinical data among the NAD+ precursor family. As of May 2026, dozens of NR human clinical trials have been completed or are ongoing worldwide, covering more than 1,000 subjects. Research spans a wide range of fields—cardiovascular health, cognitive function, exercise performance, metabolic health, sleep quality, long-COVID recovery, Alzheimer's disease, Werner syndrome, and progeria syndromes. Multiple randomized double-blind placebo-controlled trials have confirmed that oral NR effectively elevates NAD+ levels in various human tissues, with excellent tolerability at safe dosages. New clinical trials launched in 2025 are further exploring the safety of injectable NR (Niagen® Plus), the pharmacokinetic profile of subcutaneous and intramuscular injection forms, and their effect on blood NAD+ levels, marking the expansion of NR applications from oral supplements to pharmaceutical-grade injectable formulations with higher bioavailability. 3 Excellent Cellular Permeability: Natural Molecular Structure Confers Higher Bioavailability The NR molecular structure lacks a phosphate group and has a smaller molecular weight (256.26 vs. NMN's 334.22). This natural structural feature gives it higher cell membrane penetration capacity. For oral NR, it can be efficiently absorbed directly through nucleoside transporters in intestinal epithelial cells. Under specific conditions, its conversion rate to NAD+ in skeletal muscle cells is 5 times higher than that of NMN. Its excellent oral bioavailability enables stable NAD+ elevation at recommended doses of 300–1000 mg per day. 4 Extensive Academic Research and Publications Hundreds of academic papers have been published on NR-related research, covering molecular mechanisms, preclinical animal studies, and human clinical trials, including high-impact research in top international journals such as Nature, Cell, Science Advances, and Cell Metabolism. Updated review articles published in 2025 and 2026 systematically summarize major discoveries regarding NR and NMN supplementation in NAD+-related biological activities and health benefits, confirming that supplementation with either effectively elevates NAD+ levels during aging. 5 Multi-Target Health Benefits By elevating NAD+ levels, NR activates the sirtuin family of longevity proteins (serving as essential substrates for their deacetylation reactions), provides substrates for PARPs involved in DNA damage repair, and supports mitochondrial function to maintain cellular energy homeostasis. Confirmed health benefits of NR include: supporting cellular energy metabolism, improving cardiovascular and metabolic health, supporting cognitive function and neurological health, enhancing muscle function and exercise endurance, alleviating high-fat diet-induced metabolic disorders, alleviating high-fat diet-induced obesity, and supporting healthy aging. The latest research published in 2025 indicates that NR combined with aerobic exercise effectively enhances blood pressure control in mildly hypertensive middle-aged and older adults. 6 Continuously Optimized Production Processes NR production processes have evolved from initial chemical synthesis to bio-enzymatic catalysis and microbial fermentation as mainstream green manufacturing routes. Professor Chen Jian's team at Jiangnan University, in collaboration with ZEAL Biotech, has successfully constructed efficient microbial cell factories for NR synthesis through promoter design, screening of key enzymes in NR synthesis pathways, strengthening of precursor synthesis metabolic pathways, and secretion process optimization. This has achieved 10-ton scale fermentation production, significantly reducing NR production costs and making the process more environmentally friendly.